David Wilkes
Director/Board Member at BAXTER INTERNATIONAL INC.
Net worth: 654 703 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joe Almeida | M | 61 | 9 years | |
| Ron L. Meeusen | M | 72 |
ImmuneWorks, Inc.
 ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | 18 years |
| Colin Shannon | M | 65 | 1 years | |
| Reaz Rasul | M | - | 7 years | |
| Nancy Schlichting | F | 69 | 3 years | |
| Catherine Smith | F | 60 | 7 years | |
| Heather Knight | F | - | 5 years | |
| Michael Brooks | M | 50 | 3 years | |
| Amy McBride-Wendell | F | 63 | 5 years | |
| D. Shafer | M | 66 | 2 years | |
| Patricia Morrison | F | 64 | 5 years | |
| Stephen Oesterle | M | 73 | 7 years | |
| Peter Wilver | M | 64 | 2 years | |
| Brendon McDonald | M | - |
Villanova University
| - |
| John Ciccio | M | 43 | 2 years | |
| Sebastian Jano | M | - |
Villanova University
| - |
| Francis J. Horn | M | - |
Villanova University
| - |
| James R. Halstead | M | - |
Villanova University
| 9 years |
| Nnenna Lynch | F | 52 |
Villanova University
| 9 years |
| Marc Steinberg | M | - | 1 years | |
| Peter M. Donohue | M | - |
Villanova University
| 18 years |
| Joseph L. Narog | M | - |
Villanova University
| - |
| Susan Ward | F | 65 |
Villanova University
| 6 years |
| Shaun Hawkins | M | 51 |
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | - |
| James V. O'Donnell | M | - |
Villanova University
| - |
| Justin Sabet-Peyman | M | 41 | 1 years | |
| Robert E. Heideck | M | - |
Villanova University
| - |
| Thomas Naratil | M | 62 |
Villanova University
| - |
| Douglas Allen | M | - |
Villanova University
| - |
| Joseph M. Lamastra | M | 62 |
Villanova University
| - |
| Christopher DelOrefice | M | 52 |
Villanova University
| - |
| Suma Ramadas | F | - | 2 years | |
| Heather Wechet | F | - | 16 years | |
| Darla Wolfe | F | - |
Villanova University
| - |
| Joseph Genito | M | - |
Villanova University
| - |
| John A. Belperio | M | - |
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | - |
| David Rosenbloom | M | - | 2 years | |
| Caitlin Kelly | F | - | - | |
| Steve Brett | M | - | - | |
| Lynn Pawelski | F | - | 6 years | |
| Justin Gmelich | M | 55 |
Villanova University
| - |
| Ellen K. Bradford | F | - | 9 years | |
| Tobi Karchmer | M | - | 5 years | |
| John Harrobin | M | - |
Villanova University
| - |
| Sumit Khatod | M | - | 1 years | |
| Angela Lee | F | 55 | - | |
| Arthur Mbanefo | M | 57 |
Villanova University
| - |
| Hillary Bochniak | F | - | 1 years | |
| Pat LePore | M | 69 |
Villanova University
| - |
| Christopher Gheysens | M | 53 |
Villanova University
| - |
| Clare Trachtman | F | - | 24 years | |
| Melinda B. German | F | 68 |
Villanova University
| - |
| David Norman Nawrocki | M | 74 |
Villanova University
| 34 years |
| Robert McCarthy | M | 70 |
Villanova University
| - |
| James F. Orr | M | 81 |
Villanova University
| - |
| Robert Moran | M | 73 |
Villanova University
| - |
| Terrence Chew | M | - |
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | - |
| Nance Dicciani | M | 76 |
Villanova University
| 15 years |
| Reverend Donald Francis Reilly | M | 76 |
Villanova University
| - |
| Toby S. Mannheimer | F | - |
Villanova University
| - |
| Thomas Quindlen | M | 62 |
Villanova University
| 9 years |
| Jeffrey N. Pelesh | M | 65 |
Villanova University
| 34 years |
| Nicolas Roelofs | M | 66 | - | |
| Thomas F. Monahan | M | 74 |
Villanova University
| 43 years |
| James Momtazee | M | 52 | 1 years | |
| Edward Kennedy | M | 69 |
Villanova University
| - |
| Karen Leets | F | 68 | 5 years | |
| David F. Girard-diCarlo | M | - |
Villanova University
| - |
| James C. Curvey | M | 89 |
Villanova University
| - |
| Eugene Kroch | M | - |
Villanova University
| - |
| Carolyn Everson | F | 52 |
Villanova University
| - |
| William Shawn Brennan | M | 61 |
Villanova University
| - |
| James Borzi | M | 61 | 4 years | |
| Anne Roby | M | 60 |
Villanova University
| - |
| Michael Kourey | M | 64 |
Villanova University
| - |
| Ralph J. Menzano | M | - |
Villanova University
| - |
| James Dimitri | M | - | 1 years | |
| Gregory L. Schlegel | M | - |
Villanova University
| - |
| Margaret MacDonald-Sheetz | F | 46 |
Villanova University
| - |
| Nancy Mazzone | F | - |
Villanova University
| - |
| Jeanne Mason | M | 68 | 18 years | |
| Thomas Klein | M | 61 |
Villanova University
| 9 years |
| Francis J. Doyle | M | - |
Villanova University
| 9 years |
| Kenneth W. Schwenke | M | 71 |
Villanova University
| - |
| Bob J. McParland | M | - |
Villanova University
| 23 years |
| Ron Skotarczak | M | - |
Villanova University
| - |
| Rick Smith | M | - |
Villanova University
| - |
| James Sebra | M | 48 |
Villanova University
| - |
| Joseph D. Calderone | M | 75 |
Villanova University
| - |
| Chris Hsu | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Alistair Macdonald | M | 54 | 20 years | |
| Todd M. Abbrecht | M | 55 | 5 years | |
| Ken Meyers | M | 62 | 7 years | |
| Matthew Monaghan | M | 56 | 7 years | |
| John Dineen | M | 61 | 5 years | |
| Linda Harty | F | 63 | 6 years | |
| Wade A. Lange | M | - |
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | - |
| Thomas Alexander Allen | M | 46 | 4 years | |
| Bernadette Connaughton | F | 65 | 4 years | |
| Stanford Rudnick | M | 40 | 11 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Wilkes
- Personal Network
